⌘K
Loading ticker…
Abbott Laboratories · Healthcare · Pharmaceutical Products
As of 2026-06-26, Abbott Laboratories (ABT) has a 3-month relative strength percentile of 26 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 42. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.4%, relative volume 1.14×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
26 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
ABT is held by 19 ETFs as of Mar 2026. Top owner: VTI at 0.28% weight, $5.7B notional. Top 3 carry $12.5B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.28% | $5.7B |
| VOOVanguard S&P 500 ETF | 0.32% | $4.5B |
| IVViShares Core S&P 500 ETF | 0.32% | $2.3B |
| SPYState Street SPDR S&P 500 ETF | 0.32% | $2.1B |
| VTVVanguard Value ETF | 0.73% | $1.7B |
| XLVState Street Health Care Select Sector SPDR ETF | 3.37% | $1.3B |
| IWDiShares Russell 1000 Value ETF | 0.59% | $408M |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.32% | $375M |
| IVEiShares S&P 500 Value ETF | 0.66% | $308M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.28% | $224M |
Showing 10 of 19 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABT Jan avg: 0.96% median: 1.75% win: 75% σ: 10.63% n: 4 2022-04-12 → 2026-05-29 | ABT Feb avg: 2.80% median: 5.65% win: 75% σ: 7.30% n: 4 2022-04-12 → 2026-05-29 | ABT Mar avg: -5.07% median: -4.04% win: 0% σ: 4.77% n: 4 2022-04-12 → 2026-05-29 | ABT Apr avg: -3.22% median: -5.45% win: 20% σ: 7.78% n: 5 2022-04-12 → 2026-05-29 | ABT May avg: -2.26% median: -3.57% win: 40% σ: 4.89% n: 5 2022-04-12 → 2026-05-29 | ABT Jun avg: 0.72% median: 1.75% win: 75% σ: 5.99% n: 4 2022-04-12 → 2026-05-29 (current) | ABT Jul avg: -0.74% median: 1.06% win: 75% σ: 4.41% n: 4 2022-04-12 → 2026-05-29 | ABT Aug avg: -0.30% median: -0.28% win: 50% σ: 7.38% n: 4 2022-04-12 → 2026-05-29 | ABT Sep avg: -2.50% median: -2.54% win: 50% σ: 3.82% n: 4 2022-04-12 → 2026-05-29 | ABT Oct avg: -2.10% median: -1.47% win: 25% σ: 4.20% n: 4 2022-04-12 → 2026-05-29 | ABT Nov avg: 7.02% median: 6.75% win: 100% σ: 2.96% n: 4 2022-04-12 → 2026-05-29 | ABT Dec avg: 0.01% median: -0.37% win: 50% σ: 4.67% n: 4 2022-04-12 → 2026-05-29 |